CTE 2021 Q&A

  • March 9, 2022

Raphaële Mary, one of TriRadial's Vendor Outsourcing Management experts, along with Alexandra Kemmer-Brück, Senior Director of Clinical Operations at BioNTech SE, discuss Establishing Fit-for-Purpose Vendor Oversight for Emerging Biopharma during the Clinical Trials Europe conference.

During the Q&A, Raphaële expands on Alexandra's answer to the question, “How do you ensure you get the A Team when you are a small BioPharma?” by outlining several core tenets of TriRadial's approach to Vendor Oversight.

TriRadial focuses on establishing structured frameworks to enable collaborative and scalable relationships.

 

 

 

LEAVE A COMMENT

More from the Blog

Clinical Readiness Checklist

October 29, 2024
John Klein outlines the key factors TriRadial utilizes that can play a critical role in bringing you into regulatory...

Are you maximizing the value of your asset for out-licensing?

June 4, 2025
It is increasingly common for biotech companies to develop products to the point of Proof of Concept or late Phase 2...

Part 3 of the series "CAPA for non-Quality Clinical folks"

May 11, 2021
This video podcast builds off of the second episode on the Corrective Action/Preventive Action (CAPA) process and...